Ecuador Sessions: Contest for Interventionists in Training

Sponsored by Abbott Vascular LATAM

XXX SOLACI Sessions – Andean Region 10

October 6 – 7, 2016. Cuenca – Ecuador

Case Submission: “Fostering Hemodynamics among Young Cardiologists”.

contest for interventionists in trainingIt is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the next SOLACI Sessions, Cuenca-Ecuador 2016, to be held on October 6 – 7.

Participants will be competing for the “best case” prize, which consists of complete coverage to attend SOLACI 2016 in Puerto Varas, Chile: air fare, accommodation and registration.

Submitted cases must be of educational value and must pertain to the field of interventional cardiology.

All cases will be initially evaluated by the appointed committee and shortlisted to the best 8, which shall be presented orally during our sessions. During these presentations, a second complementary evaluation will decide on the winner.

Submission deadline is Friday September 9, 2016.

Submission status will be communicated on Wednesday September 14, 2016 through SOLACI web page.

 Submission Criteria and Specifications:

 

  • Case submission is meant for young Latin American interventional cardiologists only and topics include: adult peripheral vascular and structural heart interventional cardiology.

 

  • In each case only one interventionist can sign. Being a fellow cardiologist or interventionist is not required.

 

  • Attach a letter of recommendation from the Chief of the Hemodynamic Service you belong to.

 

  • Send a Word file with your case description, no longer than 300 words, font size 11.

 

  • Send a complementary Power Point file with your case presentation. Even though you may use videos for your oral presentation during our sessions (up to 5), this initial file may only include up to 5 pictures only.

 

  • One cardiologist may present more than one case. If such were the case, they should be sent separately.

 

  • Download the template to make your Power Point presentation 

 

  • Cases shall be submitted via this .

 

  • For further information about Ecuador Sessions, go .

 

Dr. Jorge Mayol

       SOLACI Session Director

Dr. Mario Araya

       SOLACI Sessions Vice Director

Dr. Ricardo Qhuizpe

               President of the Organizing Committee of SOLACI Sessions Ecuador 2016

Dr. Winston Moreira

              President of the Scientific Committee of SOLACI Sessions Ecuador 2016

Dr. Pedro Trujillo

       Coordinator of the Contest for Interventionists in Training – SOLACI Sessions

Dr. Gustavo Vignolo

       Coordinator of the Medical Image Contest – SOLACI Sessions

 

More articles by this author

Download the Official SOLACI-CACI 2024 Congress APP

  DOWNLOAD THE OFFICIAL APP OF SOLACI-CACI 2024 Next Wednesday marks the beginning of SOLACI-CACI 2024! Download the Congress APP and discover the unmissable program of the...

Survey on Hemodynamics Centers in Latin America – SOLACI, Stent Save a Life! and South American Society of Cardiology Initiative

The treatment of ST-segment elevation myocardial infarction (STEMI) in Latin America is highly diverse. There are notable differences between countries and even among regions...

SOLACI-SBHCI 2023 Congress Has Begun!

Let the best begin! After a year of intense work, SOLACI-SBHCI 2023 Congress—the widest, most important event for interventional cardiologists in Latin America—has kicked...

SOLACI-SBHCI 2023 Congress Has Begun!

Let the best begin! After a year of intense work, SOLACI-SBHCI 2023 Congress—the widest, most important event for interventional cardiologists in Latin America—has kicked...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....